ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis.

Aditya Raju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.